Advances in Research with Bryophytes
Bryophytes (mosses, liverworts, and hornworts) are the closest living relatives to the earliest land plants. During their evolution from water to land, they have adapted and developed mechanisms to sustain the dry and harsh conditions on land. As a result, bryophytes can be found in almost every land ecosystem, occurring in cold and wet arctic environments and even in hot and dry deserts. For thousands of years, bryophytes have been used by humans as part of ethno-medicinal remedies in traditional medicine, as padding material to stabilise wooden joints in clay buildings, or as filtering material to clean polluted water in latrines and fountains. These traditional uses have inspired research to explore their potential for use in biotechnology and bioengineering from various perspectives. Bryophytes are currently considered in a wide range of applications ranging from using biologically active products in medicine, agroecology and biology, as pharmaceutic flavouring agents, as part of bioreactors, biofuels, in understanding ecosystem responses to climate change, in rewilding ecosystems, in paludicultures, as bioindicators, in the filtering of pollutants, or in gardening and floristics.
To this end, a large diversity of biologically active compounds and specialized genes have been discovered in bryophytes that are absent from vascular plants. In the last decades, bryophytes such as Physcomitriella/Physcomitrium patens and Marchantia spp. have become model species in the production of biotechnologically relevant compounds that show antimicrobial, antibacterial, antifungal, antiviral and even anticancer effects. The rapidly increasing level of information on genetics has enabled functional and comparative genomic approaches and the construction of metabolic pathways promoting molecular biotechnological approaches.
All types of high-quality submissions, such as original research papers, opinions, and reviews are welcome.
Dr. Kristian Peters
Prof. Dr. Henrik Toft Simonsen
Prof. Dr. Marko Sabovljevic
- molecular biology
|Journal Name||Impact Factor||CiteScore||Launched Year||First Decision (median)||APC|
|2.4||3.1||2009||18.4 Days||CHF 2600|
|4.5||5.4||2012||15.3 Days||CHF 2700|
|-||-||2021||15.0 days *||CHF 1000|
* Median value for all MDPI journals in the first half of 2023.
Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. MDPI journals allow posting on preprint servers such as Preprints.org prior to publication. For more details about reprints, please visit https://www.preprints.org.